These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7049077)

  • 21. Aplastic anaemia associated with multidrug therapy (dapsone, rifampicin and clofazimine) in a patient with lepromatous leprosy.
    Goulart IM; Reis AC; De Rezende TM; Borges AS; Ferreira MS; Nishioka SA
    Lepr Rev; 2005 Jun; 76(2):167-9. PubMed ID: 16038251
    [No Abstract]   [Full Text] [Related]  

  • 22. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biochemical and hematological side effects of clofazimine in leprosy patients.
    Costa Queiroz RH; de Souza AM; Sampaio SV; Melchior E
    Pharmacol Res; 2002 Aug; 46(2):191-4. PubMed ID: 12220960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multi-drug therapy in bacilliferous leprosy--two years experience.
    Kaur S; Sharma VK; Kumar B; Singh M; Kaur I
    Indian J Lepr; 1985; 57(3):483-90. PubMed ID: 3831085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of acetylator phenotype on the haematological and biochemical effects associated with dapsone in leprosy patients.
    Queiroz RH; Souza AM; Melchior E; Gouveia EG; Carvalho D
    Lepr Rev; 1997 Sep; 68(3):212-7. PubMed ID: 9364821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of cefotaxime on neutrophil and lymphocyte functions.
    Van Rensburg CE; Anderson R; Eftychis HA; Jooné GK
    S Afr Med J; 1983 Sep; 64(10):346-8. PubMed ID: 6310802
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of the administration of B663 [G 30 320, Lamprene, clofazimine (Geigy)] on three groups of lepromatous and borderline of leprosy.
    Rodriguez JN; Abalos RM; Reich CV; Tolentino JG
    Int J Lepr Other Mycobact Dis; 1974; 42(3):276-88. PubMed ID: 4617715
    [No Abstract]   [Full Text] [Related]  

  • 28. Leprosy treatment during pregnancy and breastfeeding: A case report and brief review of literature.
    Ozturk Z; Tatliparmak A
    Dermatol Ther; 2017 Jan; 30(1):. PubMed ID: 27549245
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of once-monthly rifampicin and daily clofazimine on the pharmacokinetics of dapsone in leprosy patients in Nigeria.
    Pieters FA; Woonink F; Zuidema J
    Eur J Clin Pharmacol; 1988; 34(1):73-6. PubMed ID: 3360051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction of anti-leprosy drugs with the rat serum complement system.
    Sahu A; Saha K; Kashyap A; Chakrabarty AK
    Immunopharmacology; 1988; 15(3):143-50. PubMed ID: 3134310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The in vitro effects of propranolol and atenolol on neutrophil motility and post-phagocytic metabolic activity.
    Anderson R; van Rensburg AJ
    Immunology; 1979 May; 37(1):15-24. PubMed ID: 223974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of increasing weekly doses of ascorbate on certain cellular and humoral immune functions in normal volunteers.
    Anderson R; Oosthuizen R; Maritz R; Theron A; Van Rensburg AJ
    Am J Clin Nutr; 1980 Jan; 33(1):71-6. PubMed ID: 7355784
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative study of short term results in two multidrug regimens in multibacillary leprosy.
    Singh RP; Tiwari VD; Chattopadhyay SP
    Indian J Lepr; 1993; 65(2):173-80. PubMed ID: 8345231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adverse effects from multi-drug therapy in leprosy: a Brazilian study.
    Deps PD; Nasser S; Guerra P; Simon M; Birshner Rde C; Rodrigues LC
    Lepr Rev; 2007 Sep; 78(3):216-22. PubMed ID: 18035772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful plasma exchange in type 1 leprosy reversal reaction.
    Lucht F; Rifle G; Portier H; Chalopin JM; Bonhomme J
    Br Med J (Clin Res Ed); 1984 Dec; 289(6459):1647-8. PubMed ID: 6439359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of drug treatment on electroneurological measures of peripheral nerve function in leprosy patients.
    Mendis S; Somasiri KG; Chularatna W
    Ceylon Med J; 1993 Dec; 38(4):174-7. PubMed ID: 8143332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of rifampicin, clofazimine and dapsone in treating 296 cases of multibacillary leprosy].
    Li WZ
    Zhonghua Yi Xue Za Zhi; 1987 Jan; 67(1):1-3. PubMed ID: 3109697
    [No Abstract]   [Full Text] [Related]  

  • 38. Combined clofazimine- and dapsone-resistant leprosy. A case report.
    Kar HK; Bhatia VN; Harikrishnan S
    Int J Lepr Other Mycobact Dis; 1986 Sep; 54(3):389-91. PubMed ID: 3528345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of lithium on the functions of human neutrophils and lymphocytes in vitro and in vivo.
    Anderson R; Walters L; Grabow G; van der Merwe M; van Rensburg CE
    S Afr Med J; 1982 Oct; 62(15):519-23. PubMed ID: 6289478
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparative evaluation of levamisole in leprosy.
    Sharma L; Thalliath GH; Girgia HS; Sen PC
    Indian J Lepr; 1985; 57(1):11-6. PubMed ID: 3839808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.